Gain Therapeutics has launched a nine-month extension of its clinical trial testing GT-02287 as a Parkinson’s disease treatment. More than half of the patients who received GT-02287 for about three months as part of the Phase 1b clinical trial (NCT06732180), which is expected to be completed at…
A roundtable in the U.S. capital, hosted by the Parkinson’s Foundation, is aiming to find new ways to improve access to healthcare providers and treatment, define inroads for innovation, and align stronger policies in Parkinson’s disease care by centering patient and caregiver voices in a nationwide planning session. The…
A study showed that following the MIND diet — one that’s rich in vegetables, whole grains, legumes, nuts, and berries, and low in sugary, fried, and high-fat foods — may help maintain gut health in people with Parkinson’s disease by reducing the levels of zonulin, a protein that helps…
The Parkinson’s Foundation has awarded more than $1 million in community grants to fund dozens of local programs that support mental health, exercise, and education in Parkinson’s disease across 38 U.S. states, as part of its ongoing efforts to help patients live better lives. Ninety local programs…
Two trained dogs detected Parkinson’s disease with high accuracy by smelling skin swabs of patients who had not yet received treatment, adding to growing evidence that scent carries a chemical signature that could help enable early, noninvasive diagnosis. Bumper, a golden retriever, and Peanut, a black Labrador, were trained…
A weekly injectable implant could make treatment for Parkinson’s disease easier and more effective by steadily releasing levodopa and carbidopa into the bloodstream and replacing the need to take the medications multiple times a day, according to a study led by the University of South Australia (UniSA). “Our…
Aging interferes with the way neurons, or nerve cells, respond to stress, making them more susceptible to damage and more likely to contribute to neurodegenerative diseases such as Parkinson’s, according to a study in cells and brain tissue. “It’s the neuronal equivalent of being so stressed that you catch…
Researchers in Texas have discovered a promising therapeutic target for neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Using a mouse model of Alzheimer’s disease, they found that blocking the stress sensor GADD45G in astrocytes, which are star-shaped cells that support neurons, reduced the buildup of toxic proteins…
Stimulating nerve cells in a region of the brain involved in processing sound and emotions may help ease motor symptoms such as those caused by Parkinson’s disease, without unwanted side effects on emotional response, according to a study in rats. While it’s still early to understand if these…
People with Parkinson’s disease who have mild cognitive changes before deep brain stimulation (DBS) are not more likely to develop dementia later in life than those whose cognitive function was normal before the surgery, a Danish study has found. Instead, the researchers observed that dementia was more likely…
Get regular updates to your inbox.
